Kyntra Bio, Inc. (KYNB): Free Cash Flow
-$4.81M
Year ended 2025-12-31
-$38.06M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$4.81M | n/m | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | -$138.26M | n/m | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | -$317.54M | n/m | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | -$149.67M | n/m | 2024-02-26, From 2022-01-01 |
| 2021-12-31 | -$87.42M | n/m | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $77.61M | n/m | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | -$84.47M | n/m | 2022-03-04, From 2019-01-01 |
| 2018-12-31 | -$84.16M | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$75.01M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $5.86M | n/m | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | -$20.55M | n/m | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $14.30M | -25.2% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $19.11M | n/a | 2016-02-29, From 2013-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | -$4.81M | n/m |
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | -$32.83M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$29.83M | n/m |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | -$54.27M | n/m |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | -$73.61M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$18.93M | n/m |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | -$49.34M | n/m |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | -$79.08M | n/m |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | -$18.22M | n/m |
Compare KYNB, FLNA, CAMP, AARD side by side · Screen every company in Pharmaceutical Preparations ↗